Next »
Nanomedicine: Nanotechnology, Biology and Medicine
Volume 5, Issue 3
, Pages
251-273
, September 2009
Translational nanomedicine: status assessment and opportunities
-
Publication counts derived from the Thompson ISI Web of Science database on 15 March 2009 using the indicated key words. The vertical axis is the natural logarithm of the number of publications. There
Publication counts derived from the Thompson ISI Web of Science database on 15 March 2009 using the indicated key words. The vertical axis is the natural logarithm of the number of publications. There is a clear change in slope for the publications associated with biology and medicine around the year 2000.
-
Time required for maturation of science discoveries into commercial products. Courtesy of Lux Research Inc., One Liberty Square, Suite 210, Boston, Massachusetts, USA 02109.Time required for maturation of science discoveries into commercial products. Courtesy of Lux Research Inc., One Liberty Square, Suite 210, Boston, Massachusetts, USA 02109.
The Re-Engineering Basic and Clinical Research to Catalyze Translational Nanoscience workshop was funded by National Science Foundation award CBET 0805207.
PII: S1549-9634(09)00106-3
doi: 10.1016/j.nano.2009.06.001
© 2009 Elsevier Inc. All rights reserved.
Next »
Nanomedicine: Nanotechnology, Biology and Medicine
Volume 5, Issue 3
, Pages
251-273
, September 2009
